A three-way crossover study to assess the relative bioavailability of 1-mg and 4-mg tablets of S-888711 and the effect of high-fat meals on the pharmacokinetics of the 4-mg tablet in healthy male subjects
Phase 1
Completed
- Conditions
- Healthy subjects
- Registration Number
- JPRN-jRCT2080224618
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 15
Inclusion Criteria
Healthy adult male subjects between the ages >=20 and <40
Exclusion Criteria
The subject who has a history of nervous, gastrointestinal, renal, hepatic, cardiovascular, psychiatric, respiratory, metabolic, endocrine, hematic and other clinically important disorder and were considered ineligible by the investigator or subinvestigator. Subjects whose family has a history of thrombosis, coagulation disorder, or thrombocytosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method